PDR MEMBER LOGIN:
  • PDR Search

    Required field
  • Advertisement
  • FDA Date: 03/27/2014

    Zyban (bupropion hydrochloride) Sustained-Release Tablets REMS

    Goals of the Zyban (bupropion hydrochloride) Sustained-Release Tablets REMS Program

    The goal of this REMS is to inform patients about the potential serious risk of neuropsychiatric adverse events associated with the use of ZYBAN.

    REMS Elements

    • Medication Guide